News / Media

KraneShares MSCI All China Health Care Index UCITS ETF (Ticker: KURE) Launches on the London Stock Exchange

London, U.K. – 14 January 2021 – Krane Funds Advisors, LLC (“KraneShares”), a global asset management firm known for its China-focused exchange-traded funds (ETFs) and innovative China investment strategies, is pleased to announce the launch of the KraneShares MSCI All China Health Care Index UCITS ETF (Ticker: KURE) on the London Stock Exchange.

KURE tracks the performance of the MSCI China All Shares Health Care 10/40 Index, which includes publicly listed companies in Mainland China, Hong Kong, and the United States that are involved in the health care industry, specifically: patent and generic pharmaceuticals, hospital administration, biotechnology, medical equipment production, health care IT, and traditional Chinese medicine. In 2020, the index returned 68.94%*.

China is one of the fastest-growing major health care markets globally, with a five-year compound annual growth rate of 13%, compared to just 3% in the United States and 2% in Japan1. In 2015 China surpassed Japan to become the second-largest health care market globally2. Since then, total health care expenditure in China has nearly doubled from $594 billion to over $1 trillion in 20193.

There is still an opportunity for considerable growth in China’s health care market as per capita health care spending still lags other top health care markets at just $501, compared to an average of over $5,700 for the world’s top eight health care markets4.

“We believe China’s health care sector presents a compelling investment growth opportunity,” said Jonathan Krane, CEO of KraneShares. “We see several long term catalysts for the sector, including increasing demand for health care from China’s aging population, a rising middle class, increasing health care spending per capita, innovation, and technological advancement.”

For more information about KURE, visit or email [email protected].

About KraneShares
Krane Funds Advisors, LLC is the investment manager for KraneShares ETFs. The firm is focused on providing investors with strategies to capture China’s importance as an essential element of a well-designed investment portfolio. KraneShares ETFs represent innovative, first to market strategies that have been developed based on the firm and its partners’ in-depth knowledge of investing. These strategies allow investors to stay current on global market trends and provide meaningful diversification. Krane Funds Advisors, LLC is majority-owned by China International Capital Corporation (CICC).

*Data from MSCI as of 31 December 20. Index returns are for illustrative purposes only. Index performance returns do not reflect any management fees, transaction costs or expenses. Indexes are unmanaged and one cannot invest directly in an index.

  1. Statista, “Health expenditure in China from 2000 to 2018”, retrieved 31 Dec 2020.
  2. Major healthcare markets defined as top five global markets by the World Health Organization. Data from the World Health Organization as of 31 Dec 2015.
  3. Statista, “Total healthcare expenditure China 2019”, retrieved 31 Dec 2020.
  4. World Health Organization as of 31 Dec 2019, retrieved on 31 Dec 2020.